Humoral immunity in mice and man relies on the function of two developmentally and functionally distinct B cell subsets -B1 and B2 cells. While B2 cells are responsible for most of the adaptive response to environmental antigens, B1 cells, which are comprised of phenotypically distinct B1a and B1b cells, are carriers of the innate humoral immunity that relies on production of poly-reactive and low affinity antibodies. The molecular mechanism of B cell specification into different subsets is not well established. Here we identified lysine methyltransferase MMSET/NSD2 as a critical regulator of the B1 cell population. We show that NSD2 deficiency in B cell precursors prevents generation of the B1 cell compartment, while having a minor impact on B2 cells. Our data revealed MMSET/NSD2, which catalyzes histone H3 lysine 36 di-methylation, as the first in class epigenetic master regulator of a major B cell lineage in mice.
Introduction
Two developmentally and functionally distinct B cell populations support the humoral immunity in mice and man (McHeyzer-Williams, 2003) . Most peripheral B cells, which are defined as B2 cells, are generated in the bone marrow and have an immensely diverse, mostly non-self directed antibody repertoire (Yurasov and Nussenzweig, 2007) .
B2 cells can expand rapidly upon antigen stimulation followed either by immediate differentiation into antibody producing plasma cells or by the germinal center reaction and ensuing generation of cells expressing high affinity antibody (Nutt et al., 2015) . In contrast to B2 cells, B1 cells originate mostly in the yolk sack during early stages of hematopoiesis and reside predominately within well-defined anatomical compartments such as peritoneal cavity, pleural cavity and thymus (Martin and Kearney, 2001; Su and Tarakhovsky, 2000) . In contrast to B2 cells, B1 cells do not proliferate in response to antigen stimulation but divide in a seemingly autonomous fashion at a low rate (Deenen and Kroese, 1992) . The antibody repertoire of B1 cells is represented largely by selfreactive or poly-reactive antibody of low affinity, mostly of the IgM or IgG3 isotypes and IgA in mucosal surfaces (Baumgarth, 2011; Montecino-Rodriguez and Dorshkind, 2006; Rothstein, 1990) . In addition to the markedly different developmental and functional features, B1 cells display a distinct pattern of surface proteins, including CD5 or CD11b 3 that are expressed normally on T cells or macrophages, respectively (Forster et al., 1991; Ghosn et al., 2008; Su and Tarakhovsky, 2000) . Accordingly, the CD5-positive B1 cells are defined as B1a cells and the CD5-negative B1 cells as B1b cells.
The origin of B1 cells is not well established and opposing ideas have been put forward in the literature. Some findings suggest they develop from a distinctive, and predominantly fetal lineage (Hardy and Hayakawa, 1991; Hayakawa et al., 1985) , while others indicate that their phenotype is a result of the signals derived from their surface antigen receptors (Haughton et al., 1993) . These concepts may not be mutually exclusive since B1 cells expresses poly-reactive antigen receptors (Kantor et al., 1997) that could be particularly amenable to stimulation from self or environmental antigens, leading to the surface expression of characteristic markers. The discovery of B1 restricted progenitors (Montecino-Rodriguez and Dorshkind, 2006; Tung et al., 2006) and of lin28b as a key regulator of B1 cell development (Yuan et al., 2012) might support the existence of a separate lineage for these cells.
Here we present data that show the essential and selective role of histone methyltransferase MMSET/NSD2 in generation of the B1 cell population in mice.
Results and discussion

B cell specific inactivation of MMSET/NSD2
MMSET/NSD2 (hereafter NSD2, encoded by the W h s c 1 g e n e
) is one of three members of the NSD (nuclear receptor SET domain-containing) family of histone lysine methyltransferases that contain in addition to the catalytic SET domain, PHD (plant homeodomain) fingers, PWWP (Pro-Trp-Trp-Pro motif) domains, and a NSD specific C5HCH domain (a cysteine-rich domain).
The substrate specificity of NSD2, while most likely targeting the lysine 36 of histone H3, remains controversial and largely based on in vitro enzymatic assays. The methylation of lysine 36 of histone H3 has been implicated in the process of RNA elongation during transcription thus suggesting NSD2 contribution to the generation of full-length transcripts (Greer and Shi, 2012) . NSD2 function is essential for normal development in mice and humans and deficiency in NSD2 in mice leads to death of newborn mice due to severe growth retardation (Nimura et al., 2009) . NSD2 is often 4 deleted in Wolf-Hirschhorn syndrome and a great deal of attention for NSD2 stems from its link to aggressive myelomas in human. The t(4;14) translocation places the Whsc1 gene under the control of the IgH Eμ−enhancer and leads to NSD2 over-expression, which is a sign of aggressive myeloma with a poor prognosis (Keats et al., 2005) . The mechanism of NSD2 contribution to myelomagenesis and/or tumor progression is not understood.
With the aim to define the mechanism of NSD2 contribution to B cell or plasma cell malignancies, we first addressed the role of NSD2 in B cell generation and activation. To exclude NSD2 ability to mediate histone H3 methylation as well as methylation of other potential non-histone substrates, we have generated mice that allow Cre recombinase- (Hobeika et al., 2006) . Mb1-Cre mice were bred to Whsc1flSET mice and the resulting Mb1-cre; Whsc1flSET mice and the relevant littermate controls were used in our studies. We also generated Vav1-cre; Whsc1flSET mice that allow NSD2 inactivation during early stages of definitive hematopoiesis in the bone marrow (de Boer et al., 2003) .
We found that the Cre-driven modification of Whsc1 gene in Mb1-cre; Whsc1flSET mice leads to the expression of a truncated SET domain-deficient NSD2 protein (hereafter NSD2ΔSET). The expression levels of the mutant NSD2 protein levels are approximately 30% lower than the full length NSD2 protein in wild-type B cell ( Figure 1d ). cells showed only few significant changes, mainly in H3K36 methylation in addition to other modifications, which we deem secondary. By far most significant are major and selective reductions of H3K36me2 and H3K36me3 and a corresponding increase in unmodified H3K36 as compared to the histones derived from control cells (Figure 2A ,
The reduction in H3K36me2/3 methylation affects over 50% of all thus modified histones ( Figure 2B ) and the loss of H3K36me2/3 is independent of other modifications on the same histone (data not shown). This result strongly supports the H3K36me2 specificity of NSD2. ChIP-seq data for H3K36me2 shows a locus specific and significant (p-adjusted <0.05) reduction of over two-fold at 6,582 peaks and an increase of over two-fold at 548 peaks ( Figure 2C ). Sample IGV tracks confirm the locus specific changes that occur on the scale of serval to hundreds of kb ( Figure 2C ). The gain of H3K36me2 in NSD2ΔSET B cells occurred mainly in genic (64%) and promoter regions (19.4%) while the loss of H3K36me2 was observed mainly in intergenic regions (51.2%) followed by genic regions (44%) ( Figure 2D ). The selectivity of H3K36me2 down-regulation only at some gene targets suggest a locus-specific mechanism of NSD2 targeting to the chromatin in B2
cells. How such specificity is achieved remains to be understood. A likely scenario is that NSD2 is recruited to chromatin with the help of its non-catalytic domains, which differ between distinct NSD family members (Wagner a n d C a r p e n t e r , 2 0 1 2
).
Furthermore, the inactivation of the SET domain in NSD2 reproduces the effect of Whsc1 gene null-mutation. We generated mice with germ-line inactivation of SET-NSD2 followed by breeding of NSD2ΔSET to homozygosity. We found that similar to NSD2deficient mice (Nimura et al., 2009 ), NSD2ΔSET homozygous mice die early after birth.
This result allows us to relate the NSD2ΔSET mutation to NSD2 deficiency.
NSD2 is dispensable for B2 cell development and activation
The wild-type like pattern of B cell development in the bone marrow of Mb1-cre;
Whsc1flSET mice shows that NSD2 is not essential for B2 cell development ( Figure 3A) .
The unaltered pro-B to pre-B cell transition argues against a critical role of NSD2 in IgH gene rearrangement and expression as well as division of B cell progenitors. The wild-6 type like pattern of immature B2 cell generation in the bone marrow of Mb1-cre;
Whsc1flSET mice also points to a lack of NSD2 significance in processes required for surface expression of IgM and signaling required for the generation of immature B cells.
The number of re-circulating cells in the bone marrow and of follicular B2 cells in the spleen are reduced ( Figure 3B ). NSD2 might therefore play a role in the regulation of peripheral B2 cell maintenance, including B2 cell division or survival. We tested the impact of NSD2ΔSET on proliferation in response to antigen receptor-or polyclonalytriggered B cell proliferation in vitro and found no defect ( Figure 3C ). Also, the ability of B2 cell to respond to pro-survival signals such as BAFF was not affected by NSD2-SET deficiency ( Figure 3D ). Incubation of the mutant B2 cells with BAFF supports in vitro cell survival in a fashion similar to wild-type B cells. Overall, our data show a nonessential role of NSD2 in generation of the B2 cell compartment. One of the major conclusions of these studies is related to the obvious lack of NSD2 contribution to B cell division. This particular finding argues against the current view on NSD2 as an important regulator of cell proliferation.
NSD2 controls switching to IgG3 and IgA
Previous studies reported that NSD2 was required for B cell class switch recombination (Nguyen et al., 2017; Chen et al., 2018) and in accordance with these studies we also found reduced serum Ig levels of IgM, IgG3, and IgA ( Figure 4A ). Mb1-cre; Whsc1flSET mice have a reduced percentage of IgA positive B cells in Peyer's Patches ( Figure 4B ) and NSD2ΔSET B cells have a reduced ability to switch to IgA in vitro ( Figure 4C ).
Under all tested conditions, with varying amounts of TGF-β or All Trans Retinoic Acid (ATRA) NSD2ΔSET B cells are always less efficient in switching to IgA, while they maintained their ability to upregulate the integrin α4β7, a known target of RA-signaling (Iwata et al., 2004) . Similarly, switching to IgG3 in response to LPS is also impaired, while switching to IgG1 in response to LPS+IL4 showed no defect ( Figure 4D ). Apart from the switching defect we also found that the splenic germinal center response was reduced by ∼ 50% in Mb1-cre; Whsc1flSET mice in response to the model antigen Sheep
Red Blood Cells (SRBCs) but maintained the characteristic increase of cells in the light zone (LZ) ( Figure 4E ). Immunization with the T-independent model antigen NP-Ficoll resulted in the characteristic induction of antigen specific IgM, IgG3, and λ-chain carrying antibodies, with a slight reduction in the number of IgM specific antibodies at day 14 post immunization ( Figure 4F ). In response to immunization with the T-cell dependent antigen NP 22 -CGG we found a defect in the recall response to the secondary immunization for IgG1 and a general defect in the induction of antigen specific antibodies of the IgG3 isotype ( Figure 4G ). These findings argue for a role of NSD2 in isotype switching that surprisingly is restricted to a limited number of isotypes. How this specificity is achieved is currently unknown.
NSD2 is essential for generation of B1 cell compartment
Contrary to B2 cells, peritoneal B1 cells were absent in Mb1-cre; Whsc1flSET mice.
FACS analysis of peritoneal cells derived from Mb1-cre; Whsc1flSET mice show an over 12-fold reduction in the number of IgM + CD5 + CD11b + B1a cells and a nearly 3-fold reduction of the B1b cells ( Figure 5A , B). The major reduction of B1 cells numbers is mirrored by changes in serum antibody titers ( Figure 4A ). It is well established that B1 cells are the largest contributors to the overall serum levels of IgM and IgG3, which in addition to the switching defect in B2 cells ( Figure 4C , D), can explain the reduction in serum levels of these Igs. Notably the CD5 hi and phosphotidylcholine-specific BCR expressing cells are completely absent in Mb1-cre; Whsc1flSET mice ( Figure 5A ). The phosphotidylcholine specificity is determined largely by Vh11/Vh12 bearing heavy chains paired with various lights chains, most favorably Vk4 or Vk9 (Clarke and McCray, 1993) . Therefore, lack of phosphotidylcholine-specific B cells ( Figure 5C ) may potentially reflect defective Vh11/Vh12 chain rearrangement and/or expression. Analysis of NSD2 expression in B1a, B1b, and B cells of Mb1-cre; Whsc1flSET mice revealed that the residual B1 cells still express the unmodified wild-type NSD2 transcript, and were therefore not deleted for the SET domain, whereas B2 cells express only the NSD2ΔSET transcript ( Figure 5D ). To address the question whether NSD2 is essential for the generation or the maintenance of B1 cells we analyzed 3-week old mice. While littermate control mice had a large percentage of B1a and B1b cells, young Mb1-cre;
Whsc1flSET mice displayed a significant reduction in the percent and number of these populations, indicating that the development and not the maintenance of B1 cells is Understanding the exact mechanisms of NSD2 contribution to B1 cell differentiation will require the development of approaches that allow for efficient inactivation of NSD2 in B1 cells during embryonic development as well as after establishment of the mature B1
cell compartment (maintenance question). However, already at this point our highly unexpected findings revealed NSD2 as the first-in-class epigenetic master regulator of a major B cell compartment in mice. This observation, while currently limited to studies in mice, may help to understand the contribution of NSD2 malfunction to lymphoid tumor development in human. r  t  o  i  r  e  s  ,  p  o  l  y  m  o  r  p  h  i  s  m  s  ,  a  n  d  I  G  m  u  t  a  t  i  o  n  s  :  I  M  G  T Histone post translational modification analysis. Histones were extracted in acid and chemically derivatized twice, digested with trypsin, followed two more rounds of derivatization and the peptides were desalted by using C 18 stage-tips, as described earlier Cell survival assay. Purified B cells were cultured either in medium alone or in the presence of 1.56-25ng mlof recombinant BAFF for the indicated time and stained with Annexin V (Roche) and 7-aminoactinomycin D (7-AAD; Sigma-Aldrich). 
